The application of GGsTOP, a remarkably selective and potent irreversible inhibitor of GGT activity, can markedly lower the expression of GGT5, hinder the proliferation and chemotherapy resistance of lung adenocarcinoma cells [48]. The gene discussed is GGT1; the disease is lung adenocarcinoma.